
Prof Steve Davies
Founding Director
Prof Davies is a Consultant Endocrinologist at the University Hospital Wales. He has an established reputation in medical education particularly online learning, having been the founder of OnExamination.com and having set up other diploma courses. He has also been involved in establishing training courses for weight management in community pharmacy. His clinical interests include hypogonadism, growth hormone deficiency and obesity. He has published over 100 peer reviewed publications and his research interests include the application of novel technologies in delivering medical education.

Dr Ruth Davis
Academic Director
After completing a nursing degree in Cardiff, Dr Davis worked in Torbay Hospital, Torquay, before moving to Southampton where she set up the diabetes nursing service. While there Dr Davis undertook diabetes research, co-founded the Wessex Diabetes Nurses group and served on the RCN Diabetes Nursing Forum. She returned to Cardiff to teach in the College of Medicine. Following a strategic review of services Dr Davis became Diabetes Care Coordinator for Bro Taf Health Authority, managing diabetes specialist nurses, establishing Local Diabetes Service Advisory Groups, advising government on policy, developing clinical guidelines, establishing the all Wales retinal screening programme and setting up a Diabetes Centre. She moved to the University of Glamorgan (now University of South Wales) and developed a variety of courses, teaching and researching in diabetes and managing the School of Care Sciences. Dr Davis now works freelance on a variety of projects maintaining my links with diabetes and the University.

Dr Karl New
Course Lead
Dr New is currently working for the University of South Wales and has the responsibility for overseeing Exercise Physiology and Biochemistry. His first degree is in Applied Sport Science from the University of Glamorgan and he has a teaching qualification in Physical Education from UWIC alongside a Doctorate in Exercise Physiology also from the University of Glamorgan. Dr New has a keen interest in online teaching and delivering content/assessing through the digital platform.

Dr Richard Greville
Faculty Member
A graduate of Cardiff University, Richard was appointed as Director, ABPI Cymru Wales in May 2003 after serving an apprenticeship of over 15 years within the pharmaceutical industry. Since then he has enjoyed the challenges of raising the understanding and profile of the pharmaceutical industry with a range of stakeholders, including professional bodies, Welsh Assembly Members and the NHS in Wales. In 2007, Richard added the role of Director of ABPI Northern Ireland to his responsibilities. Richard is Acting Chair of the NHS-Industry Forum, a sub-group of the All Wales Medicines Strategy Group (AWMSG), working alongside colleagues from industry and the NHS in Wales. He is also a member of the Advisory Boards of the Wales Office for Research and Development in Health, and Social Care (WORD), Health Informatics Research Unit (HIRU) and the Wales Cancer Bank.

Peter Conway
Co-Course Director
Pete Conway has 20 years’ experience as both a Health Economist and Market Access Lead in the pharmaceutical industry, working across many therapeutic areas. Initially trained as a hospital/clinical pharmacist in the UK, he further developed his experience working as a Payer Pharmacist in charge of formulary control in a large tertiary care hospital.
He then trained and qualified as a Health Economist at Glaxo Welcome working in oncology and diabetes working on the first NICE submission in 1998/9. Pete has led nearly 50 health technology appraisal submissions across more than 10 brands for Wyeth Pharmaceuticals UK. As Head of EU Market Access at Wyeth, he focused on the internationalization of ENBREL, PREVENAR and EFEXOR guiding them through multiple pricing and reimbursement processes. Within inflammation, he lead the reimbursement of ENBREL in RA, psoriasis, psoriatic arthritis, and ankylosing spondylitis, and is an author on several papers relating to economics in RA, including the first economic model for biologics in RA.
More recently, he was Executive Director, Head of UK Market Access at Grunenthal UK covering health outcomes, market access marketing, government affairs and field-based payer interface specializing in the area of pain, focusing on PALEXIA and then Head of Global Market Access for Norgine Ltd.
Currently, he is working as Managing Director of ELM Market Access, supporting a number of pharmaceutical companies in HEOR services
Following my work as a Senior Cardiovascular Nurse, I ventured into the field of health economics in 2000, becoming a medical writer for DRG Abacus International. In 2006, I was promoted to Associate Director, followed by Sales Director in 2010, and finally Practice Leader/Director in 2016. Simultaneously, I worked as a Research Associate for Swansea University, where I was involved in the original proposal and concept design of the Swansea Centre for Health Economics, and secured academic research grants for health economic projects.
I’ve worked as a Research Associate and Lecturer in Health Economics/Quantitative Research at Swansea University, and was a guest lecturer for the University of Chester’s Theology MSc. Currently, I hold seminars on health economics and run a health economics special interest group for the Life Sciences Hub in Cardiff Bay.
In 2016, I set up my freelance service Gatehouse-ICS, which offers independent consultancy services and commercialisation support. My current research interests include health economics, clinical innovation, community regeneration and real world data (e.g. patient record analysis).
I’ve been working within health economics and market access for over 10 years, across pharma, consultancy and academia.
Currently, I’m the Director of HEMAR Consulting Ltd, an independent consultancy company that provides health economics, market access and reimbursement expertise to the pharma/biotech industry. Prior to this, I headed the UK Market Access startup pharma-company, where I led communications with NICE, SMC and NHS England. Between 2009-2012, I also worked as a Research Assistant in Healthcare Modelling at the University of Sheffield, and spent a further four years as the UK & Ireland Market Access Lead for Biosimilars and New Therapy Areas at Boehringer Ingelheim.
I’m a Fellow of the Higher Education Academy and have completed an M.Ed in Teaching & Learning in Higher Education (with a focus on health economics) from the University of Sheffield; an MSc in Operational Research from the University of Lancaster; and am currently studying for an MSc in Biotech Entrepreneurship at the University of Cambridge.
After qualifying with an Economics BSc from the University of Nottingham and a Health Economics MSc from the University of York, I’ve been working as a Health Economist and Policy Expert for over 15 years.
I’ve provided advice to the Department of Health and Social Care on the pricing of branded medicines, and also worked with patient groups, the NHS, and pharmaceutical companies on the economics of healthcare and pharmaceuticals. Since 2008, I’ve been running my own consulting business, Leela Barham Economic Consulting Ltd.
I’ve participated in several national and international conferences and have been published in a range of journals, including The Patient, PharmacoEconomics and Nursing Standard. In addition, I’ve also written a number of academic articles and peer-reviewed journals for Pharmaceutical Executive, The European Journal of Health Economics, and Pharmaphorum.
I completed my MPharm in 2010 from the University of Greenwich and Kent, and an MSc in Health Economics and Decision Modelling in 2015 from the University of Sheffield. After graduating I worked as a Senior Value Analyst/Health Economist at Adelphi Values, where I assisted companies in demonstrating the value of their health technologies in various healthcare systems around the world.
Since 2016, I’ve been working as a Health Economist for The National Institute for Health and Care Excellence on the Guidelines Update team. My role involves facilitating training workshops on health economics for non-economists, critically appraising clinical papers and economic analyses, and completing systematic literature reviews to identify relevant evidence.
I thoroughly enjoy facilitating student learning here at Diploma MSc. Please feel free to get in touch with me at any time, and I’ll be happy to help whenever I can!
I have more than 15 years experience in combining healthcare, public health and quality management expertise, and providing solutions needed to streamline clinical operations and deliver special patient care.
In 2012 I achieved a PhD in Public Health from Bircham International University, Madrid. Following this, I completed two Postgraduate Certificates, the former in Global Health from the University of Manchester and the latter in Public Health from the University of Hertfordshire. Recently, I began studying for my MSc in Strategic Management with the University of Derby.
I’ve also achieved several certifications, including the Certified Quality Auditor (2013), the Certified Manager of Quality/Organizational Excellence (2013) and the American Society for Quality’s Certified Six Sigma Black Belt (2014). In addition, I’ve published articles on operational excellence and leadership in healthcare, and was a contributing author on SAGE Publications’s “Encyclopedia of Crisis Management” (2013).
My current research as a physician executive focuses on developing innovative methodologies for improving health systems based on an evidence-led, decision-making process.
I’ve completed two MSc qualifications in Development Management (Distinction) from Glasgow Caledonian University and Health Policy, Planning and Finance (specialising in Health Economics) from LSE. I also hold a PhD in Health Economics from the University of South Wales, with a focus on health and behavioural economic theories.
I’ve had extensive experience in The Gambia (West Africa), where I conducted economic evaluation as the Pneumococcal Vaccine Trial Project Administrator with the Medical Research Council Laboratories (UK) between 2001-2005. I’ve also led other research projects, including a Poverty and Social Impact Analysis study on access to healthcare and basic education, and coordinated the preparation of the Poverty Reduction Strategy Paper and several Millennium Development Goals reports.
I’ve worked as a Research Fellow for several institutions, including the University of Surrey, Swansea University's Centre for Health Economics, and the Health Economics and Policy Research Unit at the University of South Wales.
-
The online Applied Health Economics Postgraduate Diploma focuses on the application of current topics and case studies to healthcare decision making. Course Code: QPDP015
-
The online Applied Health Economics MSc is designed for individuals who have an interest in a leadership role within health economics. Course Code: QMSP054